May 14 (Reuters)-
D.Western Therapeutics Institute Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2026 Mar 31, 2025 Dec 31, 2026
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 15 mln 96 mln 300 mln
(-84.4 pct) (-7.7 pct) (-22.6 pct)
Operating loss 167 mln loss 142 mln loss 780 mln
Recurring loss 170 mln loss 149 mln loss 800 mln
Net loss 170 mln loss 150 mln loss 800 mln
EPS loss 3.14 yen loss 3.41 yen loss 14.75 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T